Interestingly, EIF4A3 levels were significantly higher in TCGA patients with mutations in key HCC genes, such as TP53, CTNNB1, RB1, AXIN2, CCNE1 or CCND1 (Figure 2F). The gene discussed is AXIN2; the disease is hepatocellular carcinoma.